** Shares in Synlab SYAB.DE are up 2% in Frankfurt early
trade after the laboratory services group raised its FY
guidance, citing higher COVID-19 testing volumes urn:newsml:reuters.com:*:nASN001QC1
** Jefferies sees this development positively
** It adds the resulting higher free cash flow can be
redeployed into the group's M&A strategy and used to lower
leverage level
** The stock is among the top movers on the German small cap
SDAX .SDAXI index
(Reporting by Veronica Snoj)
((Veronica.snoj@tr.com))